Head and Neck Squamous Cell Carcinoma — Trials

Head and Neck Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,588 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 591
Recruiting: 313
Ph III recruiting: 31
Growth YoY: +29.2%
Industry share: 28%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (247)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05245682	Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer	active not recruiting	Early Phase 1	10	Emory UniversityOTHER	1	Aug 21, 2026	clinicaltrials
NCT06308913	Pembrolizumab, INCB081776, and Radiation Therapy for Head and Neck Squamous Cell Carcinoma	active not recruiting	Early Phase 1	10	University of Wisconsin, MadisonOTHER	1	May 26, 2026	clinicaltrials